EUVIMEDEUVIMED entdecken
Crossref

Cytokine profiling in COVID-19 patients by using ion mobility-mass spectrometry-based parallel reaction monitoring

Ling Yan, Chenrui Yuan, Runhou Zhou, Li Zhong, Kelvin Kai-Wang To, Na Liu, Xin Diao, Guangshan Xie, Hongzhi Zhao, Haijiang Wu, Lin Zhu, Zhiwei Chen und 1 weitere

Analytica Chimica Acta · 2025

DOI: 10.1016/j.aca.2025.344227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2025. Verfasst von Ling Yan und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Lab of Environmental and Biological Analysis, Hong Kong Baptist University, 999077, Hong Kong, China; College of Science, Eastern Institute…. Hauptthemen laut MEDLINE: COVID-19, Cytokines, Ion Mobility Spectrometry, Mass Spectrometry. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Hong Kong Baptist University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytokine therapy, a non-antigen-specific strategy, has led to several FDA-approved drugs. Given the role of dysregulated cytokine expression in diseases such as COVID-19, accurate quantification is critical in both clinical and research settings. While antibody-based assays offer high sensitivity, their reliance on specific antibodies limits multiplexing and increases analytical complexity. Conversely, mass spectrometry methods like multiplexed reaction monitoring provide higher throughput but lack the sensitivity to detect physiological cytokine levels and the resolution to distinguish structural isomers. Thus, a new MS-based approach is needed that integrates high sensitivity with the ability to resolve structurally similar cytokines. We developed an ion mobility-mass spectrometry (IM-MS)-based parallel reaction monitoring (PRM) method to establish the first Cytokine Ion Mobility Peptide (CIMP) databank and enable high-throughput cytokine profiling in serum samples from COVID-19 patients. By introducing ion mobility as an additional gas-phase separation dimension alongside liquid chromatography, the method enhances analyte resolution based on structural differences, facilitating the separation of isomers within the ion mobility trap. The incorporation of ion mobility as a complementary separation parameter enables the distinction of homologous cytokines and structural isomers (e.g., IFNA1/IFNA2, IFNL1/IFNL3, and peptide isomers), which remains challenging for conventional antibody-based assays. The method achieved a limit of detection of 62.9 fmol/L and a limit of quantification of 210 fmol/L across 31 cytokines, demonstrating greater sensitivity than traditional multiple reaction monitoring (MRM) approaches and enabling quantification at physiological concentration levels, assuming comparable background signal across platforms. The IM-MS-PRM method offers a multiplexed, high-throughput, and adaptable platform that eliminates the need for multiple assays while delivering excellent reproducibility. It enables accurate and sensitive cytokine quantification from minimal volumes of COVID-19 patient serum. Combined with the CIMP databank, this approach allows precise differentiation between early and late severe COVID-19 cases, supporting improved diagnostic and therapeutic decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19CytokinesIon Mobility SpectrometryMass SpectrometryHumansSARS-CoV-2Isomerism

Stichwörter der Autor:innen

COVID-19Cytokine profilingIon mobilityLabel-freeParallel reaction monitoring

Substanzen

Cytokines

Autor:innen und Institutionen

  • State Key Lab of Environmental and Biological Analysis, Hong Kong Baptist University, 999077, Hong Kong, China; College of Science, Eastern Institute of Technology, Ningbo, 315100, China.
  • State Key Lab of Environmental and Biological Analysis, Hong Kong Baptist University, 999077, Hong Kong, China.
  • Department of Microbiology, School of Clinical Medicine, Hong Kong University, 999077, Hong Kong, China.
  • Ministry of Education Key Laboratory of Pollution Processes and Environmental Criteria, College of Environmental Science and Engineering, Nankai University, Tianjin, 300350, China.
  • State Key Lab of Environmental and Biological Analysis, Hong Kong Baptist University, 999077, Hong Kong, China. Electronic address: zhu_lin@hkbu.edu.hk.
  • Department of Microbiology, School of Clinical Medicine, Hong Kong University, 999077, Hong Kong, China. Electronic address: zchenai@hku.hk.

Förderung

  • Hong Kong Baptist University
  • National Natural Science Foundation of China

Zitieren

APA

Yan, L., Yuan, C., Zhou, R., Zhong, L., Kai-Wang To, K., Liu, N., Diao, X., Xie, G., Zhao, H., Wu, H., Zhu, L., Chen, Z., & Cai, Z. (2025). Cytokine profiling in COVID-19 patients by using ion mobility-mass spectrometry-based parallel reaction monitoring. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2025.344227

Vancouver

Yan L, Yuan C, Zhou R, Zhong L, Kai-Wang To K, Liu N, et al. Cytokine profiling in COVID-19 patients by using ion mobility-mass spectrometry-based parallel reaction monitoring. Analytica Chimica Acta. 2025. doi:10.1016/j.aca.2025.344227

BibTeX
@article{Yan2025,
  author = {Yan, Ling and Yuan, Chenrui and Zhou, Runhou and Zhong, Li and Kai-Wang To, Kelvin and Liu, Na and Diao, Xin and Xie, Guangshan and Zhao, Hongzhi and Wu, Haijiang and Zhu, Lin and Chen, Zhiwei and Cai, Zongwei},
  title = {Cytokine profiling in COVID-19 patients by using ion mobility-mass spectrometry-based parallel reaction monitoring},
  journal = {Analytica Chimica Acta},
  year = {2025},
  doi = {10.1016/j.aca.2025.344227}
}
Kostenlos starten →